AceLink Therapeutics, Inc., a clinical-stage biotech company developing next-generation oral substrate reduction therapies (SRTs), presented interim d ...

Grants from the National Institutes of Health come with additional money for overhead. Proposed funding cuts would leave ...

TCTMD spoke with Batchelor about how executive orders on DEI and federal funding are impacting the research ecosystem.

The art of saying no in clinical trials goes beyond simply delivering news; it involves maintaining relationships and ...

Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...

IRVINE, Calif. - Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN), a biotechnology company with a market capitalization of $284.54 million and a remarkable 170% stock return over the past year according to ...

The US company’s rabies candidate, RBI-4000, was able to elicit an immune response comparable to Bavarian Nordic’s RavAvert.

MSD began worldwide recruitment for the trial and subjects are currently being enrolled. In the randomised trial, the ...